NewsRx

Search our medical news database

Enzo Biochem, Inc.

Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

Published in Healthcare Mergers, Acquisitions and Ventures Week, September 26th, 2009

Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Rodman & Renshaw Eleventh Annual Healthcare Conference on Thursday September 10, 2009, at 2:50 PM E.T. at The New York Palace Hotel in New York, N.Y.

The presentation will be accessible on the following website: http://wsw.com/webcast/rrshq15/enz and will be available in archive form for two weeks at this same website address shortly after the webcast ends....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook